Last 2,545 KRW
Change Today -125.00 / -4.68%
Volume 1.0M
049180 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 2:28 AM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

cellumed co ltd (049180) Snapshot

Open
2,690
Previous Close
2,670
Day High
2,690
Day Low
2,485
52 Week High
08/1/13 - 4,890
52 Week Low
04/1/14 - 1,895
Market Cap
70.2B
Average Volume 10 Days
713.5K
EPS TTM
-90.00
Shares Outstanding
27.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CELLUMED CO LTD (049180)

Related News

No related news articles were found.

cellumed co ltd (049180) Related Businessweek News

No Related Businessweek News Found

cellumed co ltd (049180) Details

Cellumed Co., Ltd., a biotech company, is engaged in the development of bone graft substitution based on human tissue graft in South Korea. The company provides allograft tissues, including bio-clearants; hard tissues comprising bone shaft, bone chip, and wedge/block; soft tissues, such as cartilage and ligament/tendon; skin tissues; and spinal spacers. It also offers biologics consisting of bone sponge, bone powder, demineralized bone matrix (DBM) powder, and DBM gel; and bio-similar products, which include bone morphogenetic protein 2 (BMP2) reagent and BMP2 DBM gel. In addition, the company provides medical devices that comprise spinal fixation systems, including EOS and PALLA MIS; joint replacement products, such as B-P knee, hip, and shoulder replacement products; and navigation systems that enable artificial knee joint surgery with correct positioning. Further, it is involved in the research and development of scaffolds, growth factor, and cells. Cellumed Co., Ltd. was founded in 1997 and is headquartered in Seoul, South Korea.

Founded in 1997

cellumed co ltd (049180) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

cellumed co ltd (049180) Key Developments

Cellumed Co., Ltd Proposes Amendment to Articles

Cellumed Co., Ltd. announced that it will propose amendment to Articles, at its extraordinary shareholders meeting to be held on September 3, 2014.

Cellumed Co., Ltd., Special/Extraordinary Shareholders Meeting, May 02, 2014

Cellumed Co., Ltd., Special/Extraordinary Shareholders Meeting, May 02, 2014., at 09:00 Korea Standard Time. Location: Geumcheon- digital 130 ( dong , Ace Techno Tower 9th ) cellulose Med Conference Room. Agenda: To consider the election of directors; to consider the appointment of audit; and to consider the other references concerning investment decisions.

Cellumed Co., Ltd., Annual General Meeting, Mar 28, 2014

Cellumed Co., Ltd., Annual General Meeting, Mar 28, 2014., at 09:00 Korea Standard Time. Location: dong, Geumcheon-digital 130 (dong, Ace Techno Tower 9th) cellulose Med Conference Room. Agenda: To consider the financial statements for the period form January 1, 2013 to December 31, 2013; to consider the directors remuneration limit; and to consider the audit fee limit.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
049180:KS 2,545.00 KRW -125.00

049180 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 049180.
View Industry Companies
 

Industry Analysis

049180

Industry Average

Valuation 049180 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.6x
Price/Book 1.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.1x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELLUMED CO LTD, please visit www.kbbcom.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.